Author:
Correale P,Sciandivasci A,Intrivici C,Pascucci A,Del Vecchio M T,Marsili S,Savelli V,Voltolini L,Di Bisceglie M,Guarnieri A,Gotti G,Francini G
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Arabi Y, Al Knawy B, Barkun AN, Bardou M (2006) Pro/con debate: octreotide has an important role in the treatment of gastrointestinal bleeding of unknown origin? Crit Care 10(4): 218
2. Bajetta E, Bichisao E, Artale S, Celio L, Ferrari L, Di Bartolomeo M, Zilembo N, Stani SC, Buzzoni R (2000) New clinical trials for the treatment of neuroendocrine tumors. Q J Nucl Med Mar 44(1): 96–101
3. Bajetta E, Catena L, Procopio G, Bichisao E, Ferrari L, Della Torre S, De Dosso S, Iacobelli S, Buzzoni R, Mariani L, Rosai J (2005) Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment? Ann Oncol 16(8): 1374–1380
4. Bajetta E, Procopio G, Ferrari L, Catena L, Del Vecchio M, Bombardieri E (2003) Update on the treatment of neuroendocrine tumors. Exp Rev Antican Ther 3(5): 631–642
5. Bajetta E, Rimassa L, Carnaghi C, Seregni E, Ferrari L, Di Bartolomeo M, Regalia E, Cassata A, Procopio G, Mariani L (1998) 5-Fluorouracil, dacarbazine, and epirubicin in the treatment of patients with neuroendocrine tumors. Cancer 83(2): 372–378
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献